We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Concert Pharmaceuticals Inc | NASDAQ:CNCE | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 8.37 | 8.78 | 8.00 | 0 | 01:00:00 |
|
|
|
|
|
Delaware
|
|
001-36310
|
|
20-4839882
|
(State or Other Jurisdiction
of Incorporation)
|
|
(Commission
File Number)
|
|
(IRS Employer
Identification No.)
|
|
|
|
99 Hayden Avenue, Suite 500
Lexington, Massachusetts
|
|
02421
|
(Address of Principal Executive Offices)
|
|
(Zip Code)
|
(d)
|
Exhibits
|
|
|
|
|
|
|
|
|
|
|
|
|
|
CONCERT PHARMACEUTICALS, INC.
|
|
|
|
|
|||
|
|
|
|
By:
|
|
/s/ Roger D. Tung
|
Date: August 8, 2017
|
|
|
|
|
|
Roger D. Tung
|
|
|
|
|
|
|
President and Chief Executive Officer
|
|
|
|
Exhibit
No.
|
|
Description
|
|
|
|
99.1
|
|
Press Release issued by Concert Pharmaceuticals, Inc., dated August 8, 2017
|
1 Year Concert Pharmaceuticals Chart |
1 Month Concert Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions